Renee D Goodwin1, Karina W Davidson, Katherine Keyes. 1. Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 West 168[th] Street, Room 1706, New York, NY 10032, United States. rdg66@columbia.edu
Abstract
OBJECTIVE: Numerous population-based studies have found an association between major depression and CVD, though these studies did not assess anxiety disorders. Patient samples have shown associations between anxiety disorders and cardiovascular disease (CVD), but without consideration of depressive disorders. Therefore, it remains unclear whether: (a) both anxiety and depressive disorder are associated with CVD; (b) these associations are generalizable to adults in the community. MATERIALS AND METHODS: Data were drawn from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a nationally representative sample of 43,093 civilian non-institutionalized participants aged 18 and older. RESULTS: CVD (total prevalence 3.3%) was associated with increased likelihood of any anxiety disorder (OR=1.43, (1.20, 1.71)), after adjusting for depressive disorders, as well as Generalized Anxiety Disorder (OR=1.48 (1.09, 2.01)), Panic disorder (OR=1.46 (1.12, 1.91)), and specific phobia (OR=1.29 (1.04, 1.59)). CVD was significantly associated with any mood disorder (OR=1.34 (1.13, 1.58)) after adjusting for anxiety disorders, though neither the link with major depression, nor other specific mood disorders remained significant after adjustment. CONCLUSIONS: Our findings suggest that anxiety disorders, mood disorders, and CVD are highly comorbid among adults in the United States, and demonstrate the importance of including anxiety disorder assessment in studies of mental and physical comorbidity. These results reveal how the lack of investigation into specific relationships between CVD and the range of mental disorders in population-based studies of risk factors for CVD may obscure important relationships.
OBJECTIVE: Numerous population-based studies have found an association between major depression and CVD, though these studies did not assess anxiety disorders. Patient samples have shown associations between anxiety disorders and cardiovascular disease (CVD), but without consideration of depressive disorders. Therefore, it remains unclear whether: (a) both anxiety and depressive disorder are associated with CVD; (b) these associations are generalizable to adults in the community. MATERIALS AND METHODS: Data were drawn from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a nationally representative sample of 43,093 civilian non-institutionalized participants aged 18 and older. RESULTS: CVD (total prevalence 3.3%) was associated with increased likelihood of any anxiety disorder (OR=1.43, (1.20, 1.71)), after adjusting for depressive disorders, as well as Generalized Anxiety Disorder (OR=1.48 (1.09, 2.01)), Panic disorder (OR=1.46 (1.12, 1.91)), and specific phobia (OR=1.29 (1.04, 1.59)). CVD was significantly associated with any mood disorder (OR=1.34 (1.13, 1.58)) after adjusting for anxiety disorders, though neither the link with major depression, nor other specific mood disorders remained significant after adjustment. CONCLUSIONS: Our findings suggest that anxiety disorders, mood disorders, and CVD are highly comorbid among adults in the United States, and demonstrate the importance of including anxiety disorder assessment in studies of mental and physical comorbidity. These results reveal how the lack of investigation into specific relationships between CVD and the range of mental disorders in population-based studies of risk factors for CVD may obscure important relationships.
Authors: Anastasiya Rogacheva; Tiina Laatikainen; Kerttu Tossavainen; Tiina Vlasoff; Vladimir Panteleev; Erkki Vartiainen Journal: Eur J Public Health Date: 2006-09-23 Impact factor: 3.367
Authors: John F Todaro; Biing-Jiun Shen; Susan D Raffa; Peter L Tilkemeier; Raymond Niaura Journal: J Cardiopulm Rehabil Prev Date: 2007 Mar-Apr Impact factor: 2.081
Authors: Biing-Jiun Shen; Yael E Avivi; John F Todaro; Avron Spiro; Jean-Philippe Laurenceau; Kenneth D Ward; Raymond Niaura Journal: J Am Coll Cardiol Date: 2008-01-15 Impact factor: 24.094
Authors: Jordan W Smoller; Mark H Pollack; Sylvia Wassertheil-Smoller; Rebecca D Jackson; Albert Oberman; Nathan D Wong; David Sheps Journal: Arch Gen Psychiatry Date: 2007-10
Authors: Mark R Hawes; Kimberly B Roth; Xiaoyan Wang; Ana Stefancic; Christopher Weatherly; Leopoldo J Cabassa Journal: J Health Care Poor Underserved Date: 2020
Authors: Aaron K Ho; Carolyn T Thorpe; Nancy Pandhi; Mari Palta; Maureen A Smith; Heather M Johnson Journal: J Hypertens Date: 2015-11 Impact factor: 4.844
Authors: Stefan B Rowny; Yael M Cycowicz; Shawn M McClintock; Matthew D Truesdale; Bruce Luber; Sarah H Lisanby Journal: Neuroimage Date: 2009-06-02 Impact factor: 6.556
Authors: Alessio Squassina; Mirko Manchia; Claudia Pisanu; Raffaella Ardau; Carlo Arzedi; Alberto Bocchetta; Paola Caria; Cristina Cocco; Donatella Congiu; Eleonora Cossu; Tinuccia Dettori; Daniela Virginia Frau; Mario Garzilli; Elias Manca; Anna Meloni; Maria Antonietta Montis; Andrea Mura; Mariella Nieddu; Barbara Noli; Pasquale Paribello; Federica Pinna; Renato Robledo; Giovanni Severino; Valeria Sogos; Maria Del Zompo; Gian Luca Ferri; Caterina Chillotti; Roberta Vanni; Bernardo Carpiniello Journal: Neuropsychopharmacology Date: 2020-09-12 Impact factor: 7.853
Authors: Leah M Pyter; Vanessa Pineros; Jerome A Galang; Martha K McClintock; Brian J Prendergast Journal: Proc Natl Acad Sci U S A Date: 2009-05-18 Impact factor: 11.205